High Court considers requirements for an exclusive patent licence (Neurim v Mylan)

In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This case concerned the licensing of patented technology, specifically the use of licence terms relating to the control of proceedings. 

Click here to read more >

Full article available on PatentHub

Latest insights

More Insights
featured image

Report of Trade Mark Cases For the CIPA Journal April 2025

1 minute May 20 2025

Read More
featured image

Europe's medicine supply crisis: How the EU's bold new act aims to address supply chain vulnerabilities

3 minutes May 14 2025

Read More
featured image

UK Court of Appeal reaffirms no UK SPC for second medical use

4 minutes May 14 2025

Read More